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Transcriptional Profiling after Lipid Raft Disruption
in Keratinocytes Identifies Critical Mediators of
Atopic Dermatitis Pathways
Conny Mathay1, Michael Pierre2, Mark R. Pittelkow3, Eric Depiereux2, Arjen F. Nikkels4, Alain Colige5
and Yves Poumay1
Lipid rafts are cholesterol-rich cell signaling platforms, and their physiological role can be explored by
cholesterol depletion. To characterize transcriptional changes ongoing after lipid raft disruption in epidermal
keratinocytes, a cell type that synthesizes its cholesterol in situ, we performed whole-genome expression
profiling. Microarray results show that over 3,000 genes are differentially regulated. In particular, IL-8, urokinase-
like plasminogen activator receptor, and metalloproteinases are highly upregulated after cholesterol extraction.
Quantitative reverse transcriptase PCR validation and protein release measurements demonstrate the
physiological relevance of microarray data. Major enriched terms and functions, determined by Ingenuity
Pathways Analysis, identify cholesterol biosynthesis as a major function, illustrating the specificity of
keratinocyte response toward cholesterol depletion. Moreover, the inflammatory skin disorder atopic
dermatitis (AD) is identified as the disease most closely associated with the profile of lipid raft-disrupted
keratinocytes. This finding is confirmed in skin of AD patients, in whom transcript levels of major lipid raft target
genes are similarly regulated in lesional atopic skin, compared with non-lesional and normal skin. Thus, lipid
raft disruption evokes typical features of AD, thereby suggesting that lipid raft organization and signaling could
be perturbed in atopic keratinocytes.
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INTRODUCTION
As the existence of membrane lipid rafts is now established
(Simons and Toomre, 2000; Foster, 2008), large-scale
functional studies start unraveling the relevance of lipid rafts
in cell signaling and physiology (Yaqoob and Shaikh, 2010).
Presently, lipid rafts are defined as dynamic nanoscale
membrane microdomains containing high amounts of cho-
lesterol and sphingolipids that, on activation, coalesce into
large signaling platforms (Pike, 2006, 2009). A regulated
amount of cholesterol is crucial for all animal plasma
membranes, as cholesterol helps in regulating the fluidity of
the membrane. Moreover, the presence of membrane
cholesterol and lipid raft existence is tightly related to cellular
cholesterol biosynthesis (Lange et al., 2004). In epidermis,
cholesterol is also needed for the establishment of the
cornified barrier (Wertz and Michniak, 2000), this tissue
being an active site of cholesterol synthesis. Thus, numerous
lipid raft aggregates have been found, for instance, in transit-
amplifying keratinocytes (Gniadecki and Bang, 2003).
Membrane cholesterol depletion by methyl-b-cyclodextrin
(MBCD) is known to disrupt lipid rafts in keratinocytes
(Kabouridis et al., 2000; Jans et al., 2004) and it has been
shown that the signaling molecules p38 mitogen-activated
protein kinase, extracellular signal-regulated kinase 1/2, and
epidermal growth factor receptor (EGFR) are activated and
that the expression of involucrin (IVL) and keratin 10, two
epidermal differentiation markers, is altered after lipid raft
disruption (Jans et al., 2004; Lambert et al., 2006; Mathay
et al., 2008). Parallelisms in response of keratinocytes to
cholesterol depletion or to H2O2 suggested an involvement of
oxidative mechanisms subsequent to lipid raft perturbation,
but a panel of experimental data refuted that hypothesis
(Mathay and Poumay, 2010). To acquire a global view of
transcriptional changes occurring after lipid raft perturbation
by cholesterol depletion, whole-genome transcriptional
profiling in MBCD-treated keratinocytes was performed. This
powerful technique combined with bioinformatics data
analyses allows the identification and characterization of
lipid raft-dependent transcriptional targets and cell signaling
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pathways, as well as association of functions and diseases
with lipid raft-disrupted keratinocytes. Atopic dermatitis
(AD), a skin disease characterized by allergic skin inflamma-
tion and dysfunctional epidermal barrier (Oyoshi et al.,
2009), shows strong parallelisms in expression profiles with
lipid raft-disrupted keratinocytes. Skin biopsies of AD patients
show that lipid raft disruption identifies critical mediators of
certain AD pathways.
RESULTS
Transcriptional response of lipid raft-disrupted keratinocytes
The dynamics of keratinocyte response to lipid raft disruption
by MBCD was evaluated by measuring transcript levels
immediately after cholesterol depletion (R0h) or after
recovery periods of 1 hour (R1h) and 8 hours (R8h). Time
points were chosen in accordance with previous studies
showing heparin-binding EGF-like growth factor (HB-EGF)
gene regulation, together with alterations in epidermal
differentiation markers IVL and keratin 10 (Mathay et al.,
2008). Analysis of transcripts encoded by these genes using
microarray and real-time PCR and analysis of phosphoryla-
tion of EGFR, Akt, and p38 mitogen-activated protein kinase
confirm the typical effects observed after cholesterol deple-
tion (Supplementary Figure S1 online). Expression profiling in
cholesterol-depleted keratinocytes shows that immedia-
te–early gene response to MBCD is limited to 59 genes at
R0h, 392 genes at R1h, but transcriptional changes represent-
ing 2,756 differentially regulated genes (DRGs) occur during
the 8-hour recovery phase (Supplementary Figure S1 online).
Conversely, mock cholesterol depletion by MBCD/cholester-
ol complexes induces a small number of DRGs only. Thus,
for the clarity of data presentation, comparisons between
MBCD versus control are solely illustrated. Complete lists of
DRGs for keratinocytes treated with MBCD or cholesterol-
loaded MBCD compared with controls are provided in
Supplementary Figure S2 online.
Reflecting the biological relevance of gene regulation,
DRGs were classified according to comparison fold changes
as recommended by Shi et al. (2008). In Table 1, the 20
highest fold changes (up- and downregulation) for the
comparison between MBCD versus control are shown for
each recovery period. HB-EGF is identified among the major
transcriptional targets at R0h and R1h after MBCD treatment.
Similarly, IL genes are highly responsive toward membrane
cholesterol depletion, with ILs IL-8, IL-1B, and IL-20, or
Interleukin receptors IL-13RA2, IL-1RL1, and IL-1R2, being
highly induced, especially at R8h. Most notably, proinflam-
matory cytokine IL-8 is identified as the most highly induced
gene at R1h, and is also highly induced at R8h. Other genes
involved in the inflammatory response, including prostaglan-
din-endoperoxide synthase 2 (PTGS2; cyclooxygenase (COX-
2)), plasminogen activator, urokinase receptor (PLAUR), and
the metalloproteinases (MMP1 and MMP10), are also highly
induced. However potential inflammatory responses seem
tightly regulated as the suppressor of cytokine signaling
3(SOCS3) and IL-1RL1, which functions as an anti-inflam-
matory receptor (Brint et al., 2004), are also highly expressed
after cholesterol depletion. Interestingly, members of the
epidermal differentiation complex, filaggrin (FLG), FLG-2 (a
recently identified member of the epidermal differentiation
complex; Wu et al., 2009), and cornifelin, are strongly
downregulated immediately after MBCD treatment. Further-
more, several zinc-finger transcription factors (ZNF434,
ZNF57, ZNF14) are downregulated at R1h.
Real-time PCR validation of major MBCD-transcriptional
targets
Transcript levels of several microarray-identified DRGs were
investigated by quantitative real-time PCR to ensure the
accuracy of genome expression profiling (Table 2). Gene
selection was based on their biological importance in
epidermal keratinocytes and on their differential expression
in at least two analyzed time points. When comparing both
techniques, expression values of all eight analyzed genes
indicate regulations with same directions and levels, thus
exhibiting very similar profiles. Indeed, cholesterol depletion
significantly induces activating transcription factor 3 (ATF3)
at R1h, and high expression levels of HB-EGF and IL-8 are
confirmed for all three time points. When analyzed during an
18-hour time-course experiment, the highest IL-8 gene
expression level occurs 2 hours after cholesterol depletion
(Supplementary Figure S3 online). INSIG1, a gene involved in
cellular cholesterol homeostasis, exhibits significantly in-
creased mRNA expression at R1h and R8h after cholesterol
depletion (Table 2), indicating cell reaction toward choles-
terol synthesis. Expression of matrix metalloproteinase
(MMP)1 and MMP10, key regulators of epidermal remodeling
during wound healing, is also significantly increased during
the delayed recovery phase (R8h; Table 2), with maximal
induction of MMP10 at R4h (Supplementary Figure S3
online). Interestingly, expression profiling of AD patients’
keratinocytes has also identifiedMMP1 andMMP10 as major
transcriptional targets (Lu et al., 2009). Transcript levels of the
urokinase-like plasminogen activator receptor (uPAR or
PLAUR) are highly elevated at R1h and R8h (Table 2).
Maximal PLAUR induction occurs 2 hours after MBCD
treatment (Supplementary Figure S3 online). Our data are in
accordance with a recent study of vascular smooth muscle
cells showing that cholesterol depletion also increases
PLAUR mRNA levels (Kiyan et al., 2009). Significant
increases in PTGS2 (COX-2) expression, a pivotal factor in
inflammatory processes, are detected at R1h, R2h, R4h, and
R8h after cholesterol extraction (Supplementary Figure S3
online and Table 2).
Analysis of IL-8, PLAU, and PLAUR protein expression
The protein relevance of IL-8 gene induction after cholesterol
depletion by MBCD was investigated by measurement of IL-8
release by keratinocytes (Figure 1a). Compared with control
and cholesterol-loaded MBCD-treated cells, cholesterol-
depleted keratinocytes secrete significant amounts of IL-8 as
early as 2 hours after cholesterol depletion (R2h), reaching
maximal levels at late recovery times (R8h and R18h). The
urokinase receptor system was more completely explored as
PLAUR is localized in lipid rafts (Sitrin et al., 2004) and as
PLAU (the expression of which is also augmented in case of
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Table 1. List of differentially regulated genes at recovery times 0, 1, and 8 h after cholesterol depletion by methyl-b-
cyclodextrin as identified by microarray approach
Upregulated Downregulated
Gene
symbol Gene name
Fold
change P-value
Gene
symbol Gene name
Fold
change P-value
R0h
FOS v-fos FBJ murine osteosarcoma viral
oncogene homolog
50.3 2.1E05 ASPRV1 Aspartic peptidase, retroviral-like 1 4.5 2.2E02
SOCS3 Suppressor of cytokine signaling 3 17.1 1.3E05 PTGER4 Prostaglandin E receptor 4 (subtype EP4) 3.7 1.0E02
IL8 Interleukin 8 13.4 3.1E02 FLG2 Filaggrin family member 2 3.1 2.0E02
DUSP2 Dual specificity phosphatase 2 11.2 4.9E04 FAM13B Family with sequence similarity 13,
member B
3.0 2.1E02
ZFP36 Zinc-finger protein 36, C3H type,
homolog (mouse)
9.4 1.1E02 EIF5 Eukaryotic translation initiation factor 5 2.9 2.4E15
PTGS2 Prostaglandin-endoperoxide synthase 2
(prostaglandin G/H synthase and
cyclooxygenase)
8.2 2.9E03 ZNF296 Zinc-finger protein 296 2.7 3.3E02
HBEGF Heparin-binding EGF-like growth factor 7.8 7.5E10 CYP1A1 Cytochrome P450, family 1, subfamily A,
polypeptide 1
2.5 1.6E02
IER3 Immediate early response 3 6.0 6.0E08 RPL37A Ribosomal protein L37a 2.5 4.2E02
SLC2A3 Solute carrier family 2 (facilitated glucose
transporter), member 3
5.1 4.1E02 EIF5 Eukaryotic translation initiation factor 5 2.5 2.3E08
DUSP1 Dual specificity phosphatase 1 4.6 8.3E07 ID4 Inhibitor of DNA binding 4, dominant-
negative helix–loop–helix protein
2.4 1.6E02
PTGS2 Prostaglandin-endoperoxide synthase 2
(prostaglandin G/H synthase and
cyclooxygenase)
4.5 2.0E07 CALML5 Calmodulin-like 5 2.4 2.4E04
SPRY2 Sprouty homolog 2 (Drosophila) 4.1 5.2E03 CNFN Cornifelin 2.3 7.0E05
DUSP6 Dual specificity phosphatase 6 4.1 1.1E05 KIAA1370 KIAA1370 2.3 1.8E03
CXCL2 Chemokine (C–X–C motif) ligand 2 4.1 2.4E02 CTGF Connective tissue growth factor 2.2 9.8E03
PRDM1 PR domain containing 1, with ZNF
domain
4.1 1.2E05 CST6 Cystatin E/M 2.2 5.9E04
EGR1 Early growth response 1 3.8 1.5E10 CALML3 Calmodulin-like 3 2.1 9.5E03
DUSP6 Dual specificity phosphatase 6 3.7 1.2E05 FLG Filaggrin 2.1 1.3E02
PRDM1 PR domain containing 1, with ZNF
domain
3.4 2.5E02 IFRD1 Interferon-related developmental
regulator 1
2.1 6.7E10
SLC2A3 Solute carrier family 2 (facilitated glucose
transporter), member 3
3.4 7.8E03
TFPI2 Tissue factor pathway inhibitor 2 3.2 6.5E03
R1h
IL-8 Interleukin 8 545.6 4.5E06 ZNF434 Zinc-finger protein 434 11.4 2.9E03
IL-8 Interleukin 8 449.9 3.7E06 SH3BP5L SH3-binding domain protein 5-like 5.4 3.0E02
ATF3 Activating transcription factor 3 231.8 1.0E04 CYP1A1 Cytochrome P450, family 1, subfamily A,
polypeptide 1
5.3 1.9E03
CXCL2 Chemokine (C–X–C motif) ligand 2 174.1 3.0E05 PHACTR3 Phosphatase and actin regulator 3 5.1 2.8E02
NR4A1 Nuclear receptor subfamily 4, group A,
member 1
127.2 7.7E03 NBPF1 Neuroblastoma breakpoint family,
member 1
4.3 1.0E02
EGR2 Early growth response 2 124.2 6.4E03 C7orf68 (HIG2) Chromosome 7 open reading frame 68
(hypoxia inducible gene 2)
4.2 6.5E04
IL-20 Interleukin 20 117.2 1.3E03 ZNF57 Zinc-finger protein 57 3.9 2.1E04
SLC2A3 Solute carrier family 2 (facilitated glucose
transporter), member 3
105.9 1.1E04 ZNF14 Zinc-finger protein 14 3.9 1.1E02
DUSP2 Dual specificity phosphatase 2 78.9 4.5E07 ZNF557 Zinc-finger protein 557 3.9 2.9E02
PLAUR Plasminogen activator, urokinase receptor 78.1 1.2E06 ZNF12 Zinc-finger protein 12 3.8 2.9E02
PLAUR Plasminogen activator, urokinase receptor 76.4 1.5E05 MGC16385 Hypothetical protein MGC16385 3.7 3.9E03
FOS v-fos FBJ murine osteosarcoma viral
oncogene homolog
71.3 5.4E06 ZNF12 Zinc-finger protein 12 3.6 2.4E06
SOCS3 Suppressor of cytokine signaling 3 62.6 2.2E06 ASPRV Aspartic peptidase, retroviral-like 1 3.6 3.7E03
APOBEC3A Apolipoprotein B mRNA editing enzyme,
catalytic polypeptide-like 3A
54.5 7.1E04 ATPIF1 ATPase inhibitory factor 1 3.5 9.6E03
NR4A2 Nuclear receptor subfamily 4, group A,
member 2
52.9 6.9E12 C13orf15 Chromosome 13 open reading frame 15 3.5 3.0E04
Table 1 contained on the following page
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cholesterol extraction; Supplementary Figure S2 online)
binding to its receptor stimulates cholesterol synthesis (Fuhr-
man et al., 2007). Highly significant extracellular PLAU
release actually occurs between R4h and R8h after the initial
cholesterol depletion (Figure 1b). This time schedule exactly
corresponds to the recovery period during which the PLAUR
protein expression is induced in keratinocytes (Figure 1c),
suggesting potential ligand-induced PLAUR activation during
this period.
Network and pathway exploration of DRG after membrane
cholesterol depletion
To identify potential regulatory networks and pathways from
microarray data, lists of DRG after MBCD treatment were
uploaded into the bioinformatics tool Ingenuity Pathways
Analysis (IPA). IPA’s capacity of discriminating relevant
functions, pathways, and networks was checked with random
gene lists. In reality, IPA analysis reveals that ‘‘cholesterol
biosynthesis’’ and ‘‘hormone receptor-regulated cholesterol
Table 1. Continued
Upregulated Downregulated
Gene
symbol Gene name
Fold
change P-value
Gene
symbol Gene name
Fold
change P-value
PTGS2 Prostaglandin-endoperoxide synthase 2
(prostaglandin G/H synthase and
cyclooxygenase)
51.8 2.4E06 ZNF112 Zinc-finger protein 112 homolog (mouse) 3.4 3.2E03
GEM GTP-binding protein overexpressed in
skeletal muscle
44.5 1.7E04 C7orf68 (HIG2) Chromosome 7 open reading frame 68
(hypoxia inducible gene 2)
3.4 1.4E04
HBEGF Heparin-binding EGF-like growth factor 44.4 5.6E14 ALG12 Asparagine-linked glycosylation 12, a-
1,6-mannosyltransferase homolog
(Saccharomyces cerevisiae)
3.3 1.9E02
SLC2A3 Solute carrier family 2 (facilitated glucose
transporter), member 3
42.8 4.0E10 FAM13B Family with sequence similarity 13,
member B
3.3 9.3E04
ATF3 Activating transcription factor 3 38.0 1.7E03 LOC643008 Hypothetical protein LOC643008 3.2 6.2E03
R8h
IL1RL1 Interleukin 1 receptor-like 1 2688.5 4.5E08 IFIT1 Interferon-induced protein with
tetratricopeptide repeats 1
159.8 6.5E04
MMP10 Matrix metallopeptidase 10 (stromelysin
2)
740.7 2.5E06 SLC40A1 Solute carrier family 40 (iron-regulated
transporter), member 1
154.4 2.0E07
IL13RA2 Interleukin 13 receptor, a-2 306.0 2.4E07 EEF2K Eukaryotic elongation factor-2 kinase 97.7 1.2E04
IL1R2 Interleukin 1 receptor, type II 289.7 1.5E05 RAB7B RAB7B, member RAS oncogene family 95.8 1.7E09
LBH Limb bud and heart development
homolog (mouse)
270.8 1.4E06 TNS3 Tensin 3 90.7 5.2E07
SPRY2 Sprouty homolog 2 (Drosophila) 265.5 5.3E06 ZBTB16 Zinc-finger and BTB domain containing
16
81.8 1.5E04
PTGS2 Prostaglandin-endoperoxide synthase 2
(prostaglandin G/H synthase and
cyclooxygenase)
230.0 8.5E09 SP100 SP100 nuclear antigen 65.2 2.8E04
TFPI2 Tissue factor pathway inhibitor 2 221.0 2.9E10 FOXN3 Forkhead box N3 63.6 8.4E06
ZBED2 Zinc-finger, BED-type containing 2 199.7 8.6E08 SKP2 S-phase kinase-associated protein 2 (p45) 61.7 4.6E06
IL-1R2 Interleukin 1 receptor, type II 192.9 1.1E05 GHR Growth hormone receptor 59.8 1.7E06
DEFB103A Defensin-b 103A 155.6 1.6E02 ANLN Anillin, actin-binding protein 55.1 3.1E07
BMP6 Bone morphogenetic protein 6 141.1 6.9E06 BTN3A2 Butyrophilin, subfamily 3, member A2 54.6 5.0E05
CEACAM1 Carcinoembryonic antigen-related cell
adhesion molecule 1 (biliary
glycoprotein)
133.0 6.3E08 ID3 Inhibitor of DNA binding 3, dominant-
negative helix–loop–helix protein
53.1 3.6E05
AKAP12 A kinase (PRKA) anchor protein 12 121.5 3.5E06 METTL7A Methyltransferase like 7A 46.0 3.0E08
MUM1L1 Melanoma associated antigen (mutated)
1-like 1
117.6 1.2E05 SULT1E1 Sulfotransferase family 1E, estrogen-
preferring, member 1
44.1 1.7E04
INHBA Inhibin b-A 114.7 6.7E05 DEPDC7 DEP domain containing 7 44.1 5.3E06
IL-1B Interleukin 1-b 109.6 1.8E09 SULT1E1 Sulfotransferase family 1E, estrogen-
preferring, member 1
42.4 4.9E04
MMP1 Matrix metallopeptidase 1 (interstitial
collagenase)
103.2 4.6E08 MYCL1 v-Myc myelocytomatosis viral oncogene
homolog 1, lung carcinoma derived
(avian)
36.9 2.1E05
IL-8 Interleukin 8 100.1 1.5E03 KRT2 Keratin 2 35.8 8.0E04
AGPAT9 1-Acylglycerol-3-phosphate O-
acyltransferase 9
100.0 1.0E06 SMAD5OS SMAD family member 5 opposite strand 35.8 1.1E06
Abbreviations: ATP, adenosine-5’-triphosphate; EGF, epidermal growth factor; GTP, green florescent protein; R0h, cholesterol depletion at 0 hours; R1h, at
1 hour; R8h, at 8 hours.
Shown are the 20 most highly up- and downregulated genes classified according to their fold change (for all genes: adjusted P-values o0.05).
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metabolism’’ are major cellular processes associated with
DRG 8hours after cholesterol depletion (Figure 2a). The gene
ontology term ‘‘cholesterol biosynthesis’’ contains a set of 16
involved genes, of which 10 are DRGs in the R8h data set
(Figure 2b). Among these are key enzymes of cholesterol
synthesis, 3-hydroxy-3-methyl-glutaryl-coenzyme A reduc-
tase, 3-hydroxy-3-methyl-glutaryl-coenzyme A synthase 1,
7-dehydrocholesterol reductase, and squalene epoxidase,
which are all highly upregulated in these conditions. Thus,
keratinocytes respond to cholesterol depletion by inducing
Table 2. Gene expression levels in methyl-b-cyclodextrin-treated cells compared with untreated keratinocytes1
Microarray
Probe set number Probe set number Probe set number
Gene symbol Gene name Recovery time
Real-time PCR
Fold change2 Fold change P-value Fold change P-value Fold change P-value
HG-U133_Plus_2HF29032 HG-U133_Plus_2HF13723 HG-U133_Plus_2HF20755
ATF3 Activating transcription factor 3 0h 1.15±0.24 15.58 2.2E01 2.05 2.1E01 2.24 2.0E04
1h 18.19±6.56 231.84 1.0E04 37.98 1.7E03 20.67 1.5E09
8h 1.57±0.42 1.00 2.7E01 3.96 7.5E03 1.75 2.3E02
HG-U133_Plus_2HF20822
HBEGF Heparin-binding EGF-like
growth factor
0 h 3.12±0.69 7.79 7.5E10
1h 27.27±11.19 44.45 5.6E14
8h 21.57±4.00 33.67 3.9E13
HG-U133_Plus_2HF13928 HG-U133_Plus_2HF19869
IL-8 Interleukin 8 0h 5.08±1.94 13.39 3.1E02 2.43 3.3E02
1h 104.47±43.82 545.62 4.5E06 449.87 3.7E06
8h 43.89±10.46 100.11 1.5E03 37.60 9.9E05
HG-U133_Plus_2HF10596 HG-U133_Plus_2HF2065
INSIG1 Insulin-induced gene 1 0h 1.03±0.05 1.57 8.9E04 1.39 5.9E01
1h 3.68±0.88 7.65 4.2E12 4.36 2.9E02
8h 6.15±1.41 10.58 2.1E10 26.46 2.2E02
HG-U133_Plus_2HF11142
MMP1 Matrix metalloproteinase 1 0h 1.44±0.24 2.71 1.4E02
1h 3.98±1.17 5.80 1.5E06
8h 114.26±46.68 103.24 4.6E08
HG-U133_Plus_2HF6142
MMP10 Matrix metalloproteinase 10 0h 1.28±0.07 1.23 3.4E01
1h 2.84±0.90 4.94 1.6E02
8h 307.47±92.43 740.68 2.5E06
HG-U133_Plus_2HF18124 HG-U133_Plus_2HF21107 HG-U133_Plus_2HF3386
PLAUR Plasminogen activator receptor,
urokinase type (uPAR)
0 h 1.12±0.05 1.02 6.5E01 2.36 7.1E03 2.88 3.5E02
1h 31.13±8.83 10.24 6.6E04 76.40 1.5E05 78.06 1.2E06
8h 15.48±2.28 18.06 2.6E04 32.27 9.5E07 27.52 3.6E04
HG-U133_Plus_2HF19274 HG-U133_Plus_2HF7077
PTGS2 Prostaglandin-endoperoxide
synthase 2 (COX-2)
0 h 2.08±0.39 8.16 2.9E03 4.48 2.0E07
1h 7.87±2.06 51.81 2.4E06 11.52 6.1E08
8h 26.50±10.65 229.97 8.5E09 75.86 1.7E06
Abbreviations: COX-2, cyclooxygenase 2; EGF, epidermal growth factor; FC, fold change; uPAR; urokinase-like plasminogen activator receptor.
1Differentially regulated genes are highlighted in gray (quantitative reverse transcriptase PCR: Student’s t-test with Po0.05; microarray: 2oFCo2 and
adjusted P-value o0.05).
2Mean fold changes±SEM from three independent experiments.
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the transcription of genes encoding cholesterol synthesis
enzymes as early as 8 hours after MBCD treatment.
Functional IPA annotation (Supplementary Figure S4
online) illustrates that two categories of diseases, namely,
‘‘reproductive system disease’’ and ‘‘dermatological diseases
and conditions’’, are major gene ontology terms associated
with DRG at R0h, R1h, and R8h. These bioinformatics results
might be explained by the fact that steroid hormones are
1,800
1,200
600
0
20,000
15,000
10,000
5,000
0
Ex
tra
ce
llu
la
r P
LA
U 
re
le
as
e 
(pg
 m
l–1
)
377
4732
147 205 174 137
659407
2407**
1178 1336 1620
4682 4506
7905
13234
**
444
3088**
**
Ctrl MBCD MBCD/chol
Ctrl MBCD MBCD/chol
2810
441
33 25**185 16E
xt
ra
ce
llu
la
r I
L-
8 
re
le
as
e 
(pg
 m
l–1
)
*
R0h R1h R2h R4h R8h R18h
PLAUR
Actin
Ct
rl
M
BC
D
Ct
rl
M
BC
D
Ct
rl
M
BC
D
Ct
rl
M
BC
D
Ct
rl
M
BC
D
Ct
rl
M
BC
D
M
BC
D/
ch
ol
M
BC
D/
ch
ol
 R
 8
h
R0h R1h R2h R4h R8h R18h
R0h R1h R2h R4h R8h R18h
182
5973365319
1060
1265
** 1265
**
**
**
Figure 1. PLAUR expression, and PLAU and IL-8 release after cholesterol depletion. Functional time-course analysis shows that MBCD induces PLAUR protein
expression, as well as PLAU and IL-8 protein release. (a) Extracellular IL-8 release subsequent to MBCD and MBCD/chol treatments (means±SEM; n¼ 4).
(b) Extracellular PLAU release subsequent to MBCD and MBCD/chol treatments (means±SEM; n¼ 3). (c) Western blot analysis of PLAUR protein expression
in cell lysates of cholesterol-depleted keratinocytes (representative data obtained from three independent experiments). chol, cholesterol; Crtl, control,
MBCD, methyl-b-cyclodextrin; PLAU, plasminogen activator urokinase; PLAUR, plasminogen activator urokinase receptor; R0h, cholesterol depletion at
0 hours; R1h, at 1 hour; R2h, at 2 hours; R4h, at 4 hours, R18h, at 18 hours. *Po0.05; **Po0.01; Dunnett’s test.
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produced from cholesterol and that cholesterol depletion
perturbs endocrine steroid regulatory mechanisms.
Potential networks for cholesterol-depleted keratinocytes
generate previously unreported working hypotheses and
identify critical mediators of AD pathways
At R0h after cholesterol depletion, a potential network
involving TGFB1, IL-6, and IL-8 is suggested by IPA analysis.
The presence of PTGS2, activating transcription factor 3, and
PLAUR in this network is remarkable (Figure 3a).
Thereafter, a second network centered on tumor necrosis
factor-a is top-scored at time point R1h (Figure 3b), featuring
HB-EGF, IL-8, PTGS2, and MMP1 as possibly tumor necrosis
factor-a-regulated genes in cholesterol-depleted keratino-
cytes. Interestingly, ‘‘dermatological diseases and condi-
tions’’ and ‘‘inflammatory disease’’ are key terms associated
with this network.
Finally, at time point R8h, the inflammatory network
prevails, featuring ILs-1a and -b as central factors. In this
network, MMP1, 3, and 9, as well as PTGS2 and IL-8, have
very important roles (Figure 3c).
Functional annotation analysis of DRGs revealed that
‘‘dermatological diseases and conditions’’ was a function
strongly associated with R0h and R1h data sets, a highly
interesting result as standard IPA settings were used. Therefore,
we investigated which dermatological disease associates best.
AD associates the most significantly with the transcriptional
profile observed at R0h, and AD is second at R1h after lipid raft
disruption by MBCD (Supplementary Figure S5 online).
Intersection of MBCD-regulated genes and genes related to
AD include IL-8, PTGS2, IL-1RN, SOCS3, DUSP1, DUSP2,
DUSP5, and transcription factors JUN, JUNB, and ZFP36 (all
of which are upregulated) and the only downregulated
epidermal gene FLG (Supplementary Figure S5 online).
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Figure 2. Differentially regulated genes. Illustration of the most highly represented functional groups from the list of differentially regulated genes R8h
(cholesterol depletion at 8 hours) (a) and details on genes involved in the cholesterol biosynthesis pathway (b). (a) Ingenuity Pathway Analysis (IPA)-generated
major functions of differentially regulated genes at R8h. Light gray: downregulated gene expression; dark gray: upregulated gene expression. In all, 10 of
the 16 genes present in the group ‘‘cholesterol biosynthesis’’ are regulated (corresponding to 62.5%), one gene is downregulated (6.25%), and nine genes
are upregulated (56.25%). (b) IPA list of the 16 genes involved in ‘‘cholesterol biosynthesis’’ and their fold changes and P-values when differentially regulated
in the methyl-b-cyclodextrin R8h dataset.
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Having identified a potential relationship between cho-
lesterol depletion and AD, links between dermatitis and the
top-scored networks were found, and highlighted in blue in
Figure 3. Each of the networks illustrates at least five genes
involved in the disease, suggesting that cholesterol depletion
could mimic certain features of AD.
Transcript levels of cholesterol-regulated genes that are
members of the epidermal differentiation cluster are shown in
Figure 4a. To test whether cholesterol depletion has crucial
effects on genes that are deregulated in AD, skin biopsy
specimens of acute lesions and surrounding normal-appear-
ing skin of AD patients (average age: 39 years), as well as
biopsy specimens of healthy volunteers (average age: 43
years), were collected after informed consent. When per-
forming comparisons between groups of AD patients and
healthy persons, no age-related effects were observed. Using
real-time PCR, transcript levels of several major targets of
cholesterol depletion were analyzed (Figure 4b–h). The mean
expression of late differentiation markers FLG and loricrin
(LOR) is approximately twofold significantly decreased in AD
skin (either lesional or non-lesional) when compared with
healthy skin (Figure 4b and c). Inside or outside AD lesions,
no difference in the expression of these two genes could be
detected. IVL and transglutaminase (TGM-1) exhibit similar
mRNA levels in both healthy and non-lesional AD skin,
whereas expression of these two genes is increased for every
patient, leading to a significant mean increase in IVL and
TGM-1 in lesional compared with non-lesional AD skin
(Figure 4d and e). In healthy patients, the expression level of
HB-EGF presents a high variability, especially in two
samples, probably as a consequence of the collecting
procedure, HB-EGF being an early stress-responsive gene
(Mathay et al., 2008). In samples from AD patients, the non-
lesional HB-EGF expression level is low but increases
significantly in lesional areas of most AD patients (Figure
4f). Similarly, IL-8 transcript levels exhibit particularly high
values in lesional AD skin, compared with either non-lesional
areas or healthy samples (Figure 4g), revealing the important
inflammatory response in acute AD lesions. Regarding
PLAUR expression levels, no tendency in expression can be
detected between healthy and non-lesional AD skin; how-
ever, each AD patient reveals an increase in PLAUR transcript
levels in lesions compared with levels in non-lesional
areas (Figure 4h) and the average PLAUR expression is
significantly increased in lesional AD skin. Thus, elevated
IL-8, PLAUR, HB-EGF, and TGM1 expression can be
considered as a previously unreported gene signature of
inflammatory lesional AD plaques.
a
b
c
Cytokine/growth factor
Enzyme
G-protein coupled receptor
Growth factor
Ligand-dependent nuclear receptor
Peptidase
Phosphatase
Transcription regulator
Transmembrane receptor
Unknown
Figure 3. Potential networks and interactions. Illustration of potential
networks showing relevant genes and their possible interactions, either
immediately after cholesterol depletion (at 0 hours (R0h (a)) or after recovery
times of 1 hour (R1h (b)) or 8 hours (R8h (c)). Full arrows indicate direct
interactions, whereas dotted arrows indicate indirect interactions.
Upregulated genes are indicated in red color, whereas green color indicates
downregulated genes. Intense colors indicate high fold changes. Genes
known to be involved in dermatitis are indicated by blue lines. The shape of
the node indicates the major function of the protein. Data were analyzed by
the Ingenuity Pathway Analysis 7.5 tool. ATF3, activating transcription factor;
HB-EGF, heparin-binding EGF-like growth factor; MMP1, metalloproteinase 1;
PLAUR, plasminogen activator urokinase receptor; PTGS2, prostaglandin-
endoperoxide synthase 2.
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In summary, when comparing AD skin with normal skin,
increased expression levels of IVL, TGM1, HB-EGF, IL-8, and
PLAUR are detected simultaneously with a decreased
expression of FLG and LOR. These observations are in good
concordance with transcriptional analysis of gene expression
in lipid raft-disrupted keratinocytes, strongly suggesting that
membrane organization and signaling might be disturbed in
AD keratinocytes.
DISCUSSION
Genome expression profiling in cholesterol-depleted kerati-
nocytes reveals hundreds of DRGs as an immediate or later
consequence of lipid raft disruption. Such a strong transcrip-
tional regulation may likely be explained by the fact that lipid
rafts are known to host large numbers of signaling molecules
that cannot form competent signaling assemblies after
cholesterol extraction. Data presented here illustrate that
processes initiated by cholesterol depletion are complex and
dynamic, involving IL-8, HB-EGF, and PLAUR, for instance,
among major transcriptional targets, an observation con-
firmed by protein analysis and showing the physiological
importance of cholesterol-dependent gene expression in
keratinocytes.
IL-8 and PLAU induction and secretion, together with HB-
EGF release (Giltaire and Poumay, unpublished results), as a
consequence of lipid raft disruption are to our best knowl-
edge previously unreported results. IL-8 is an inflammatory
marker induced by various stress signals and recently EGFR-
dependent IL-8 synthesis has been shown in wounded
keratinocytes, a process that contributes to injury-initiated
neutrophil recruitment (Roupe´ et al., 2010).
Highly elevated PLAUR transcript levels are also detected
after cholesterol depletion (Figure 1). The urokinase system
PLAU/PLAUR is mainly known for its fibrinolytic function
during tissue remodeling; however, PLAUR is also involved
in cell adhesion, migration, and signaling (Ragno, 2006;
Caceres et al., 2008). Further investigations of this urokinase
system represent promising areas of research because
cholesterol biosynthesis is increased not only by PLAU
binding to its receptor (Fuhrman et al., 2007) but also
because PLAU secretion and increased PLAUR expression are
induced as a response to cholesterol depletion. Thus, the
PLAU/PLAUR system may be suspected to enhance choles-
terol biosynthesis. Moreover, PLAU binding to its receptor
increases the lipid raft affinity of this GPI-anchored receptor
(Sahores et al., 2008). In prostate cells, PLAU is able to
stimulate autocrine HB-EGF production, thereby maintaining
EGFR activation (Caceres et al., 2008). A similar mechanism
might function in keratinocytes after cholesterol depletion as
PLAU secretion is observed (Figure 1b) and HB-EGF is
simultaneously released (Giltaire and Poumay, in prepara-
tion). Furthermore, it has been shown that, in keratinocytes,
EGFR activation depends on PLAUR membrane expression
(D’Alessio et al., 2008). EGFR is activated immediately after
cholesterol depletion (Jans et al., 2004; Lambert et al., 2008),
probably because the required basal PLAUR levels are
present, but PLAUR levels are also highly increased during
the recovery period after cholesterol depletion. Finally, our
data concur with a study conducted on vascular smooth
muscle cells showing PLAUR induction following cholesterol
depletion (Kiyan et al., 2009).
In our present data, gene ontology analysis of DRG after
cholesterol depletion in keratinocytes has pointed out AD as
the dermatological disease that best fits the gene regulation
obtained by cholesterol depletion. Thus, we tested whether
major genes regulated after lipid rafts disruption by choles-
terol depletion could similarly be regulated in AD skin
biopsies. Indeed, data revealed good concordance between
AD and lipid raft disruption.
Since the discovery of an increased risk of AD in patients
carrying FLGmutations (Palmer et al., 2006), the involvement
of epidermal differentiation cluster genes in etiopathology of
AD has drawn considerable scientific interest. In AD skin, a
decreased expression of FLG is generally observed (Sugiura
et al., 2005; Guttman-Yassky et al., 2009) and might
contribute to the impaired epidermal barrier of acute AD
lesions. Our data also illustrate significantly decreased FLG
and LOR expression in AD, together with increased IVL,
perfectly matching literature data (Sugiura et al., 2005;
Howell et al., 2007; Jarzab et al., 2010), as well as data
observed in cholesterol-depleted keratinocytes. Thus, three
members of the epidermal differentiation cluster are similarly
regulated in AD and in keratinocytes with disrupted lipid
rafts. In addition, an interesting increase in SOCS3 expression
and PLAUR activity is detected in AD (Saaf et al., 2008;
Voegeli et al., 2009), similar to that in cholesterol-depleted
keratinocytes. Finally, although individual gene expression
variations occur, no particular age-related effect could be
identified between cohorts of patients.
Intriguing parallelisms in our data strongly suggest that
keratinocyte lipid rafts could be involved in the etiopathology
of AD, maybe by impaired lipid raft organization or perturbed
signaling in AD. Interestingly, during the process of epider-
mal barrier maturation, lamellar bodies exhibit properties of
lipid rafts (Menon, 2003); indeed lamellar bodies are
enriched in caveolin-1, a lipid raft marker protein (Sando
et al., 2003), and the fusion of lamellar bodies with the apical
plasma membrane of granular keratinocytes is regulated by
Figure 4. Gene expression in keratinocytes and skin samples. Relative mRNA expression levels of genes of the epidermal differentiation cluster are analyzed in
cholesterol-depleted keratinocytes (a) and gene transcript levels are analyzed in lesional and non-lesional skin of seven atopic dermatitis (AD) patients and in
skin of eight healthy volunteers (b–h). Demographic data are available in Supplementary Table S2. Expression levels of filaggrin (FLG, b), loricrin (LOR, c),
involucrin (IVL, d), transglutaminase-1 (TGM1, e), HB-EGF (heparin-binding EGF (epidermal growth factor)-like growth factor, f), IL-8 (g), and PLAUR
(plasminogen activator urokinase receptor, h) were normalized to the average expression of two housekeeping genes (RPLP0 and TBP). Values are expressed
relatively to the means of eight healthy volunteers. Statistical analyses were performed by a paired Wilcoxon signed-rank test for the comparison of lesional
versus non-lesional AD skin (D: Po0.05) and by a Mann–Whitney test (Bonferroni corrected) for the comparisons of lesional versus healthy skin and of
non-lesional versus healthy skin (*Po0.05, **Po0.01). –, mean value; ctrl, control; FC, fold change; FLG2, filaggrin-2.
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membrane cholesterol (Roelandt et al., 2009). Thus, as a
correct exocytosis of lamellar bodies is required for the
function of the epidermal barrier, and as lamellar body
formation and delivery mechanisms are perturbed in AD,
leading to an impaired epidermal barrier (Fartasch et al.,
1992), the functioning of keratinocyte lipid rafts could be
compromised in AD. Moreover, a profiling study in AD
patients has recently revealed a marked differential
regulation of genes involved in lipid biosynthesis (Saaf
et al., 2008), genes that are also regulated after lipid
raft disruption (Figure 2). These data provide additional
support for the hypothetical involvement of lipid rafts in
AD. Finally, data from recent literature demonstrate that
miltefosine, an alkylphospholipid with high affinity for lipid
rafts (Barratt et al., 2009) and presented as a potential lipid
raft modulator, can significantly attenuate allergic sensitiza-
tion (Weller et al., 2009). Miltefosine has also been
successfully tested in mice and human AD treatment
(Ba¨umer et al., 2010; Do¨lle et al., 2010), bringing an
additional argument for our hypothesis.
Altogether, this study first contributes to a better knowl-
edge of epidermal lipid rafts and their associated signaling, as
it demonstrates their physiological relevance in keratinocytes
in inducing IL-8, PLAU, and PLAUR, in addition to HB-EGF.
Second, the detailed analysis of signaling pathways perturbed
by lipid raft disruption has identified crucial mediators
involved in the etiopathology of AD.
MATERIALS AND METHODS
Chemicals and culture media
MBCD and cholesterol were obtained from Sigma-Aldrich (Bornem,
Belgium). Keratinocyte growth medium 2 was purchased from
Clonetics (Lonza, Verviers, Belgium). Keratinocyte complete culture
medium (Epilife with human keratinocyte growth supplement) and
keratinocyte autocrine culture medium (Epilife without human
keratinocyte growth supplement) were from Cascade Biologics
(Invitrogen, Merelbeke, Belgium).
Skin biopsies and culture of human normal epidermal keratinocytes
This study was conducted in accordance with the Declaration of
Helsinki. The study was approved by the Ethics Committee of the
University Hospital Center of Lie`ge and by the medical ethical
committee of Clinique St Luc, Namur. The whole procedure of the
study was fully explained to all volunteers who gave their written
informed consent. None of the AD patients were receiving any
topical or systemic therapy other than hydrating creams. Supple-
mentary Table S2 online summarizes demographic data of seven AD
volunteers suffering from longstanding AD who underwent a skin
biopsy on lesional and surrounding non-lesional skin and of eight
healthy volunteers. Superficial 2mm punch biopsies, composed of
mainly epidermis with minimal dermis amounts, were taken from
AD patients under local anesthesia and then stored in RNAlater
(Qiagen, Venlo, The Netherlands) before RNA extraction (RNeasy
Micro, Qiagen) and real-time PCR analysis. For healthy samples and
in vitro culture experiments, abdominal or breast skin samples
obtained from plastic surgery were used and keratinocyte cultures
were grown in autocrine culture medium until confluence as
described earlier(Minner et al., 2010).
Lipid raft disruption by cholesterol depletion
Cholesterol depletion in confluent keratinocyte cultures was
performed by 7.5mM (1% wt/vol) MBCD for 1 hour. For mock
cholesterol depletion (negative control), cells were incubated for
1 hour with 7.5mM cholesterol-loaded MBCD complexes (cholester-
ol-loaded MBCD; Klein et al., 1995). Cells were harvested either
immediately after MBCD treatment (R0h) or were allowed to recover
in autocrine culture medium for 1 hour (R1h) or 8 hours (R8h).
Microarray and bioinformatics analyses
Detailed microarray and bioinformatics analyses are described in
Supplementary Methods online. Briefly, tRNA integrity was analyzed
(Agilent 2100 Bioanalyzer; Agilent, Santa Rosa, CA) and whole-
genome expression levels were determined on Affymetrix HG-U133
Plus 2.0 GeneChips (Affymetrix, Sunnyvale, CA). Probe sets with a
fold change42 oro2 and a P-value lower than 0.05 were defined
to be differentially regulated and were selected for further analyses.
In compliance with minimum information about a microarray
experiment standards, data files were deposited into the NCBI Gene
Expression Omnibus. The Gene Expression Omnibus accession
number is GSE21364. http://www.ncbi.nlm.nih.gov/geo/query/ac-
c.cgi?acc=GSE21364.
Network generation and functional analysis of microarray data
Lists of DRGs with associated fold changes and P-values were
imported into the Ingenuity Pathway Analysis 7.5 tool (Ingenuity
Systems, Redwood City, CA). The basis of the IPA tool consists of the
Ingenuity Pathway Knowledge Base, which is derived from known
functions and published gene interactions. The most relevant
biological networks, functions, or pathways of a data set were
identified by a Fischer’s exact test computing a P-value that
determines the probability that the network, function, or pathway
assigned to that data set is because of chance alone.
Real-time PCR protocol and primer sequences (Supplementary
Table S1 online) are available in online Supplementary Methods
online.
Protein extraction and western blotting
Immediately after the indicated treatments, cells were washed with
phosphate-buffered saline and harvested in twice-concentrated
Laemmli sample buffer without dithiothreitol (62.5mM Tris–HCl,
2% SDS, 8.7% glycerol, 0.05% bromophenol blue). Proteins were
analyzed by SDS-PAGE and by blotting onto polyvinylidene fluoride
membranes (GE Healthcare Bio-Sciences, Uppsala, Sweden).
Blocking of the membrane was followed by incubation with primary
antibodies against PLAUR (R&D Systems, Abigdon, UK) and b-actin
(Sigma-Aldrich, Bornem, Belgium), followed by incubation with
secondary antibodies. Chemoluminescent detection was carried out
as described previously (Mathay et al., 2008).
IL-8/PLAU measurement
IL-8 and PLAU protein concentrations were measured in cell culture
medium using commercial quantitative sandwich immunoassays
(Duoset, R&D systems, Abigdon, UK). Each sample was assayed in
duplicate according to the manufacturer’s instructions, and detection
was carried out at 450nm (wavelength correction: 540nm) in a
microplate reader (VersaMax Molecular Devices, Sunnyvale, CA). IL-8
and PLAU concentrations were calculated following standard curves.
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